Cleared Traditional

K200886 - StimSite

K200886 is the FDA 510(k) clearance for StimSite by Allotrope Medical, Inc.. It is a Class 2 Obstetrics & Gynecology device (product code ETN) cleared through the Traditional 510(k) pathway after a 222-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
222d
Days
Class 2
Risk

K200886 is an FDA 510(k) clearance for the StimSite. Classified as Stimulator, Nerve (product code ETN), Class II - Special Controls.

Submitted by Allotrope Medical, Inc. (Houston, US). The FDA issued a Cleared decision on November 10, 2020 after a review of 222 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 874.1820 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Allotrope Medical, Inc. devices

Submission Details

510(k) Number K200886 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 02, 2020
Decision Date November 10, 2020
Days to Decision 222 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d slower than avg
Panel avg: 160d · This submission: 222d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code ETN Stimulator, Nerve
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 874.1820
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Acknowledge Regulatory Strategies, LLC
Allison Komiyama

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - ETN Stimulator, Nerve

All 37
Devices cleared under the same product code (ETN) and FDA review panel - the closest regulatory comparables to K200886.
Mapping Suction Probe
K212164 · Inomed Medizintechnik GmbH · Nov 2022
NIM Surgeon Control Probe, Prass Tip, NIM Surgeon Control Probe, 1mm Ball Tip, NIM Surgeon Control Probe, 1mm Ball Tip, 35cm Long
K213246 · Medtronic Xomed, Inc. · Mar 2022
Checkpoint Guardian Intraoperative Lead, Medium, Checkpoint Guardian Intraoperative Lead, Large
K212355 · Checkpoint Surgical · Aug 2021
ES2 NEUROMONITORING ACCESSORY INSTRUMENTS
K140400 · Stryker Corporation · Jul 2014
NEXT GEN EMG ENDOTRACHEAL TUBE
K112686 · Medtronic Xomed, Inc. · Jun 2012
NUVASIVE NVJJB SYSTEM
K112717 · Nuvasive, Inc. · Apr 2012